| |
| |
|
| Insider
Information: |
El Coronado Holdings, Llc |
| Relationship: |
10% Owner |
| City: |
Pearce |
| State: |
AZ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
6,674,725 |
|
|
Indirect Shares
|
27,131,085 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$11,304,639 |
|
|
| Total
Shares |
33,805,810 |
|
|
| Total
Value |
$11,304,639 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nmi Health Inc |
NANM |
10% Owner |
2005-03-02 |
0 |
2009-06-22 |
9,805,857 |
Premium* |
|
|
Novogen Limited (ADR) |
NVGN |
10% Owner |
2006-04-21 |
0 |
2013-11-05 |
385,749 |
Premium* |
|
|
Chelsea Therapeutics Internation... |
CHTP |
10% Owner |
2007-03-22 |
0 |
2012-12-17 |
6,432,673 |
Premium* |
|
|
MEI Pharma Inc |
MEIP |
10% Owner |
2012-12-03 |
0 |
2012-12-03 |
3,832,081 |
Premium* |
|
|
Protea Biosciences Group Inc |
PRGB |
10% Owner |
2013-12-30 |
6,674,725 |
2013-12-30 |
6,674,725 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
289 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-06-07 |
4 |
B |
$5.24 |
$13,532 |
I/I |
2,584 |
2,959,340 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-07 |
4 |
B |
$9.20 |
$9,241 |
I/I |
1,005 |
2,427,060 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-08 |
4 |
B |
$9.35 |
$74,818 |
I/I |
8,000 |
2,435,060 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-06-08 |
4 |
B |
$5.27 |
$22,034 |
I/I |
4,181 |
2,963,521 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-06-12 |
4 |
B |
$5.21 |
$41,654 |
I/I |
8,000 |
2,971,521 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-12 |
4 |
B |
$9.10 |
$23,414 |
I/I |
2,573 |
2,437,633 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-06-13 |
4 |
B |
$5.22 |
$19,408 |
I/I |
3,716 |
2,975,237 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-13 |
4 |
B |
$8.93 |
$89,324 |
I/I |
10,000 |
2,447,633 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-06-14 |
4 |
B |
$5.20 |
$45,661 |
I/I |
8,781 |
2,984,018 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-14 |
4 |
B |
$8.55 |
$47,907 |
I/I |
5,600 |
2,453,233 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-06-15 |
4 |
B |
$5.43 |
$55,384 |
I/I |
10,200 |
2,994,218 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-18 |
4 |
B |
$8.30 |
$13,986 |
I/I |
1,685 |
2,454,918 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-19 |
4 |
B |
$8.47 |
$91,452 |
I/I |
10,800 |
2,465,718 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-20 |
4 |
B |
$8.20 |
$125,074 |
I/I |
15,244 |
2,480,962 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-21 |
4 |
B |
$8.48 |
$35,458 |
I/I |
4,183 |
2,485,145 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-22 |
4 |
B |
$8.60 |
$60,182 |
I/I |
7,000 |
2,492,145 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-06-26 |
4 |
B |
$5.75 |
$2,875,000 |
I/I |
500,000 |
3,494,218 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-28 |
4 |
B |
$8.40 |
$202,440 |
I/I |
24,100 |
2,516,245 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-07-02 |
4 |
B |
$6.35 |
$476,250 |
I/I |
75,000 |
3,569,218 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-07-10 |
4 |
B |
$6.98 |
$550,406 |
I/I |
78,805 |
3,648,023 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-07-10 |
4 |
B |
$8.40 |
$1,679,000 |
I/I |
200,000 |
2,716,245 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-07-13 |
4 |
B |
$6.93 |
$2,120,580 |
I/I |
306,000 |
3,954,023 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-07-20 |
4 |
B |
$6.38 |
$63,750 |
I/I |
10,000 |
3,964,023 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-07-25 |
4 |
B |
$6.39 |
$454,511 |
I/I |
71,173 |
4,035,196 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-07-26 |
4 |
B |
$6.28 |
$140,672 |
I/I |
22,400 |
4,057,596 |
1.5 |
- |
|
289 Records found
|
|
Page 6 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
